NSX. in a related area ( vascular surgery ). U might look at SILK.
Important data to be released at conference June 12th .
With both of these SWAV and SILK ....important improvements on standard approach's and will be widely adopted IMHO ...its just a question of how fast . With SWAV we should see how fast in their next earning report . They had standing room only in some of their sessions at the last EU conference Kiwi